-+ 0.00%
-+ 0.00%
-+ 0.00%

Abpro Holdings and Celltrion Submit IND for Phase 1 Trial of ABP-102/CT-P72 in HER2-Positive Cancers

Reuters·12/15/2025 12:00:19

Please log in to view news